Platelets in Non-alcoholic Fatty Liver Disease
Non alcoholic steatohepatitis (NASH) is the inflammatory reaction of the liver to excessive accumulation of lipids in the hepatocytes. NASH can progress to cirrhosis and hepatocellular carcinoma (HCC). Fatty liver is the hepatic manifestation of metabolic syndrome. A subclinical inflammatory state i...
Main Authors: | Andrea Dalbeni, Marco Castelli, Mirko Zoncapè, Pietro Minuz, David Sacerdoti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.842636/full |
Similar Items
-
Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice
by: Nana Makiuchi, et al.
Published: (2023-09-01) -
Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis
by: Yuki Tada, et al.
Published: (2022-10-01) -
Non-alcoholic fatty liver disease: Definition and subtypes
by: Seul Ki Han, et al.
Published: (2023-02-01) -
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
by: Alessandro Mantovani, et al.
Published: (2022-02-01) -
Treatments for NAFLD: State of Art
by: Alessandro Mantovani, et al.
Published: (2021-02-01)